Signal transduction by cGMP-dependent protein kinases and their emerging roles in the regulation of cell adhesion and gene expression.

[1]  S. Lohmann,et al.  Cyclic-GMP-Dependent Protein Kinase Inhibits the Ras/Mitogen-Activated Protein Kinase Pathway , 1998, Molecular and Cellular Biology.

[2]  U. Walter,et al.  Endogenous or overexpressed cGMP-dependent protein kinases inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  U. Walter,et al.  Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO/cGMP effects , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  P. Klatt,et al.  Defective smooth muscle regulation in cGMP kinase I‐deficient mice , 1998, The EMBO journal.

[5]  V. Coghlan,et al.  Identification of cGMP-dependent protein kinase anchoring proteins (GKAPs). , 1998, Biochemical and biophysical research communications.

[6]  U. Walter,et al.  Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. , 1998, Circulation research.

[7]  T. Haystead,et al.  Acceleration of Myosin Light Chain Dephosphorylation and Relaxation of Smooth Muscle by Telokin , 1998, The Journal of Biological Chemistry.

[8]  Silber,et al.  Expression of cGMP‐dependent protein kinase I and its substrate VASP in neointimal cells of the injured rat carotid artery , 1998, European journal of clinical investigation.

[9]  T. Lincoln,et al.  Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  N. Tamura,et al.  Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Houtsmuller,et al.  Membrane targeting of cGMP-dependent protein kinase is required for cystic fibrosis transmembrane conductance regulator Cl- channel activation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Granger,et al.  Nitric Oxide Is an Upstream Signal of Vascular Endothelial Growth Factor-induced Extracellular Signal-regulated Kinase½ Activation in Postcapillary Endothelium* , 1998, The Journal of Biological Chemistry.

[13]  T. Lincoln,et al.  Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells. , 1998, Circulation research.

[14]  S. Kourembanas,et al.  Carbon Monoxide Controls the Proliferation of Hypoxic Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[15]  G. Garcı́a-Cardeña,et al.  Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.

[16]  J. Corbin,et al.  Activation by Cyclic GMP Binding Causes an Apparent Conformational Change in cGMP-dependent Protein Kinase* , 1997, The Journal of Biological Chemistry.

[17]  T. Billiar,et al.  Nitric Oxide Inhibits Apoptosis by Preventing Increases in Caspase-3-like Activity via Two Distinct Mechanisms* , 1997, The Journal of Biological Chemistry.

[18]  S. Schwartz.  Smooth muscle migration in atherosclerosis and restenosis. , 1997, The Journal of clinical investigation.

[19]  R. Cummings,et al.  Role of PSGL-1 binding to selectins in leukocyte recruitment. , 1997, The Journal of clinical investigation.

[20]  T. Lincoln,et al.  Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP. , 1997, The Journal of clinical investigation.

[21]  H. Krell,et al.  β1 Integrin Is Essential for Teratoma Growth and Angiogenesis , 1997, The Journal of cell biology.

[22]  J. Yoshikawa,et al.  Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. , 1997, Circulation research.

[23]  S. Lohmann,et al.  Regulation of gene expression by cyclic GMP-dependent protein kinase requires nuclear translocation of the kinase: identification of a nuclear localization signal , 1997, Molecular and cellular biology.

[24]  K. Burridge,et al.  Focal adhesion assembly. , 1997, Trends in cell biology.

[25]  A. Schally,et al.  Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Bloch,et al.  Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. , 1997, The Journal of clinical investigation.

[27]  R. Greenspan,et al.  Natural behavior polymorphism due to a cGMP-dependent protein kinase of Drosophila. , 1997, Science.

[28]  U. Walter,et al.  Distinct and specific functions of cGMP-dependent protein kinases. , 1997, Trends in biochemical sciences.

[29]  R. Cummings,et al.  Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. , 1997, The Journal of clinical investigation.

[30]  H. Tajiri,et al.  Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells , 1997, Oncogene.

[31]  T. Lincoln,et al.  Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. , 1997, Journal of vascular research.

[32]  D. Garbers,et al.  New insights on the functions of the guanylyl cyclase receptors , 1997, FEBS letters.

[33]  R Bicknell,et al.  Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.

[34]  K. Taskén,et al.  Characterization of the Human Gene Encoding the Type Iα and Type Iβ cGMP-Dependent Protein Kinase (PRKG1) , 1997 .

[35]  G. Garcı́a-Cardeña,et al.  Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. , 1997, The American journal of pathology.

[36]  J. Stockand,et al.  Regulation of Large Calcium-activated Potassium Channels by Protein Phosphatase 2A* , 1997, The Journal of Biological Chemistry.

[37]  R. Stockert,et al.  Cytoplasmic Protein mRNA Interaction Mediates cGMP-modulated Translational Control of the Asialoglycoprotein Receptor* , 1997, The Journal of Biological Chemistry.

[38]  L. Hung,et al.  cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. , 1997, Circulation.

[39]  Shuibang Wang,et al.  Nitric Oxide Increases Tumor Necrosis Factor Production in Differentiated U937 Cells by Decreasing Cyclic AMP* , 1997, The Journal of Biological Chemistry.

[40]  Toshio Kitazawa,et al.  Cyclic GMP Causes Ca2+ Desensitization in Vascular Smooth Muscle by Activating the Myosin Light Chain Phosphatase* , 1997, The Journal of Biological Chemistry.

[41]  S. Lohmann,et al.  cGMP Stimulation of Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels Co-expressed with cGMP-dependent Protein Kinase Type II but Not Type Iβ* , 1997, The Journal of Biological Chemistry.

[42]  C. Teng,et al.  Inhibition of platelet adhesion to collagen by cGMP-elevating agents. , 1997, Biochemical and biophysical research communications.

[43]  J. Zwiller,et al.  Immediate early gene induction by natriuretic peptides in PC12 phaeochromocytoma and C6 glioma cells , 1997, Neuroreport.

[44]  N. Morgan,et al.  Evidence for the involvement of cGMP and protein kinase G in nitric oxide‐induced apoptosis in the pancreatic B‐cell line, HIT‐T15 , 1997, FEBS letters.

[45]  F. Hofmann,et al.  Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II , 1996, Science.

[46]  N. Kawada,et al.  Smooth muscle alpha-actin expression in rat hepatic stellate cell is regulated by nitric oxide and cGMP production. , 1996, Biochemical and Biophysical Research Communications - BBRC.

[47]  P. Kubes,et al.  A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. , 1996, Circulation research.

[48]  U. Ikeda,et al.  Nitric oxide attenuates adhesion molecule expression in human endothelial cells. , 1996, Cytokine.

[49]  T. Saruta,et al.  Regulation of obese mRNA expression by hormonal factors in primary cultures of rat adipocytes. , 1996, European journal of endocrinology.

[50]  J. Beavo,et al.  Multiplicity within cyclic nucleotide phosphodiesterases. , 1996, Biochemical Society transactions.

[51]  T. Lincoln,et al.  Cyclic GMP-dependent protein kinase is required for thrombospondin and tenascin mediated focal adhesion disassembly. , 1996, Journal of cell science.

[52]  P. Tsao,et al.  Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1. , 1996, Circulation.

[53]  M. Horiuchi,et al.  Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. , 1996, Circulation research.

[54]  F. Hofmann,et al.  Protein Phosphatase 2A Is Essential for the Activation of Ca2+-activated K+ Currents by cGMP-dependent Protein Kinase in Tracheal Smooth Muscle and Chinese Hamster Ovary Cells* , 1996, The Journal of Biological Chemistry.

[55]  U. Walter,et al.  Expression of type II cGMP-dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression. , 1996, The Journal of clinical investigation.

[56]  P. Chiu,et al.  In vivo inhibition of platelet adhesion by a cGMP-mediated mechanism in balloon catheter injured rat carotid artery. , 1996, Pharmacology.

[57]  H. Ziegler-Heitbrock,et al.  CCAAT/enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes. , 1996, Cytokine.

[58]  A. Morrison,et al.  Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. , 1996, The Journal of clinical investigation.

[59]  Y. Lau,et al.  Nitric oxide inhibits migration of cultured endothelial cells. , 1996, Biochemical and biophysical research communications.

[60]  A. Yamaguchi,et al.  Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells. , 1996, Biochemical and biophysical research communications.

[61]  S. Lohmann,et al.  Regulation of Gene Expression by cGMP-dependent Protein Kinase , 1996, The Journal of Biological Chemistry.

[62]  J. Elferink,et al.  The role of cyclic nucleotides in neutrophil migration. , 1996, General pharmacology.

[63]  R. Sarkar,et al.  Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. , 1996, Circulation research.

[64]  W. Wetsel,et al.  NMDA and nitric oxide act through the cGMP signal transduction pathway to repress hypothalamic gonadotropin‐releasing hormone gene expression. , 1996, The EMBO journal.

[65]  K. Guan,et al.  Atrial Natriuretic Peptide Induces the Expression of MKP-1, a Mitogen-activated Protein Kinase Phosphatase, in Glomerular Mesangial Cells (*) , 1996, The Journal of Biological Chemistry.

[66]  David A. Cheresh,et al.  Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.

[67]  A. Nairn,et al.  Isotype-specific Activation of Cystic Fibrosis Transmembrane Conductance Regulator-Chloride Channels by cGMP-dependent Protein Kinase II (*) , 1995, The Journal of Biological Chemistry.

[68]  U. Walter,et al.  Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. , 1995, Circulation research.

[69]  A. Yamaguchi,et al.  Reciprocal regulation by cyclic nucleotides of the differentiation of rat osteoblast-like cells and mineralization of nodules. , 1995, Biochemical and biophysical research communications.

[70]  D. Gardner,et al.  Atrial Natriuretic Peptide Suppresses the Transcription of Its Guanylyl Cyclase-linked Receptor (*) , 1995, The Journal of Biological Chemistry.

[71]  M. Kohno,et al.  Inhibition by cardiac natriuretic peptides of rat vascular endothelial cell migration. , 1995, Hypertension.

[72]  U. Kaupp,et al.  Family of cyclic nucleotide gated ion channels , 1995, Current Opinion in Neurobiology.

[73]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[74]  T. Lüscher,et al.  Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. , 1995, The Journal of clinical investigation.

[75]  P. Libby,et al.  Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*) , 1995, The Journal of Biological Chemistry.

[76]  F. Hofmann,et al.  Cyclic GMP-dependent Protein Kinase Blocks Pertussis Toxin-sensitive Hormone Receptor Signaling Pathways in Chinese Hamster Ovary Cells (*) , 1995, The Journal of Biological Chemistry.

[77]  T. Lincoln,et al.  Localization of cyclic GMP‐dependent protein kinase in human mononuclear phagocytes , 1995, Journal of leukocyte biology.

[78]  J. Meinkoth,et al.  Nitric oxide and cGMP analogs activate transcription from AP‐1‐responsive promoters in mammalian cells , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  G. Boss,et al.  Isolation and characterization of HL-60 cells resistant to nitroprusside-induced differentiation. , 1994, The Journal of biological chemistry.

[80]  H. Genieser,et al.  (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. , 1994, European journal of pharmacology.

[81]  U. Walter,et al.  Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. , 1994, European journal of biochemistry.

[82]  A. M. Lefer,et al.  Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. , 1994, Gastroenterology.

[83]  U. Walter,et al.  Cloning, expression, and in situ localization of rat intestinal cGMP-dependent protein kinase II. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[84]  U. Walter,et al.  NO at work , 1994, Cell.

[85]  G. Werner-Felmayer,et al.  Neopterin derivatives together with cyclic guanosine monophosphate induce c‐fos gene expression , 1994, FEBS letters.

[86]  U. Walter,et al.  Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors. , 1994, The American journal of physiology.

[87]  H. Johnston,et al.  NMDA and Nitric Oxide Increase Microtubule‐Associated Protein 2 Gene Expression in Hippocampal Granule Cells , 1994, Journal of neurochemistry.

[88]  P. Kubes,et al.  Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. , 1994, Circulation research.

[89]  M. Krieger,et al.  cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. , 1994, The Journal of biological chemistry.

[90]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[91]  N. Chua,et al.  Cyclic GMP and calcium mediate phytochrome phototransduction , 1994, Cell.

[92]  J. Zwiller,et al.  Stimulation of the Cyclic GMP Pathway by NO Induces Expression of the Immediate Early Genes c‐fos and junB in PC12 Cells , 1994, Journal of neurochemistry.

[93]  L. Sanders,et al.  Transcriptional regulatory elements downstream of the JunB gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[94]  R. Tsien,et al.  Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A , 1993, Molecular and cellular biology.

[95]  G. Enikolopov,et al.  Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells , 1993, Nature.

[96]  J. Elferink,et al.  The effect of cyclic GMP and cyclic AMP on migration by electroporated human neutrophils. , 1993, European journal of pharmacology.

[97]  P. Kubes,et al.  Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. , 1993, Circulation research.

[98]  M. Uhler.  Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain. , 1993, The Journal of biological chemistry.

[99]  U. Walter,et al.  Defective nitrovasodilator-stimulated protein phosphorylation and calcium regulation in cGMP-dependent protein kinase-deficient human platelets of chronic myelocytic leukemia. , 1993, The Journal of biological chemistry.

[100]  R. Penner,et al.  Transfected cGMP-dependent protein kinase suppresses calcium transients by inhibition of inositol 1,4,5-trisphosphate production. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[101]  J. Economou,et al.  The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. , 1992, The Journal of biological chemistry.

[102]  C. Venturini,et al.  Platelet cGMP, but not cAMP, inhibits thrombin-induced platelet adhesion to pulmonary vascular endothelium. , 1992, The American journal of physiology.

[103]  H. Itoh,et al.  Atrial Natriuretic Polypeptide as a Novel Antigrowth Factor of Endothelial Cells , 1992, Hypertension.

[104]  F. Hofmann,et al.  Structure and physiological role of cGMP-dependent protein kinase. , 1992, Biochimica et biophysica acta.

[105]  U. Walter,et al.  Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells. , 1992, European journal of biochemistry.

[106]  K. Nishimaki,et al.  Impairment of L-arginine metabolism in spontaneously hypertensive rats. , 1992, Biochemistry international.

[107]  U. Walter,et al.  Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[108]  M. Karin,et al.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. , 1991, Biochimica et biophysica acta.

[109]  T. Lincoln,et al.  Vimentin is transiently co-localized with and phosphorylated by cyclic GMP-dependent protein kinase in formyl-peptide-stimulated neutrophils. , 1991, The Journal of biological chemistry.

[110]  G. Schultz,et al.  Guanylyl cyclases, a growing family of signal‐transducing enzymes , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  U. Walter,et al.  Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating factors. , 1991, The Journal of biological chemistry.

[112]  J. Auwerx,et al.  Activation of junB by PKC and PKA signal transduction through a novel cis-acting element. , 1991, Nucleic acids research.

[113]  D. Gemsa,et al.  Enhancement of tumor necrosis factor-alpha gene expression by low doses of prostaglandin E2 and cyclic GMP. , 1990, Immunobiology.

[114]  H. Itoh,et al.  Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. , 1990, The Journal of clinical investigation.

[115]  T. Lincoln,et al.  Compartmentalization of cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. , 1990, Blood.

[116]  F. Hofmann,et al.  Decreased Cardiac Concentration of cGMP Kinase in Hypertensive Animals An Index for Cardiac Vascularization? , 1989, Circulation research.

[117]  D. Kalderon,et al.  Molecular cloning and predicted full‐length amino acid sequence of the type Iβ isozyme of cGMP‐dependent protein kinase from human placenta , 1989 .

[118]  F. Hofmann,et al.  The cDNA of the two isoforms of bovine cGMP‐dependent protein kinase , 1989, FEBS letters.

[119]  G. Rubin,et al.  cGMP-dependent protein kinase genes in Drosophila. , 1989, The Journal of biological chemistry.

[120]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[121]  R. Roeder,et al.  Multiple sequence elements in the c-fos promoter mediate induction by cAMP. , 1989, Genes & development.

[122]  U. Walter,et al.  Cyclic nucleotide elevating vasodilators inhibit platelet aggregation at an early step of the activation cascade. , 1989, European journal of pharmacology.

[123]  S Moncada,et al.  The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. , 1987, Biochemical and biophysical research communications.

[124]  H. Cheng,et al.  Differential and common recognition of the catalytic sites of the cGMP-dependent and cAMP-dependent protein kinases by inhibitory peptides derived from the heat-stable inhibitor protein. , 1986, The Journal of biological chemistry.

[125]  B. Levy,et al.  Increased cyclic GMP levels lead to a stimulation of elastin production in ligament fibroblasts that is reversed by cyclic AMP. , 1985, The Journal of biological chemistry.

[126]  R. D. Wade,et al.  Guanosine cyclic 3',5'-phosphate dependent protein kinase, a chimeric protein homologous with two separate protein families. , 1984, Biochemistry.

[127]  T. Lincoln,et al.  Purification and subunit composition of guanosine 3':5'-monophosphate-dependent protein kinase from bovine lung. , 1977, The Journal of biological chemistry.

[128]  G. M. Walton,et al.  Purification and characterization of 3':5'-cyclic GMP-dependent protein kinase. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[129]  J. Kuo,et al.  Depressed cardiac cyclic GMP-dependent protein kinase in spontaneously hypertensive rats and its further depression by guanethidine , 1976, Nature.

[130]  P. Greengard,et al.  Cyclic nucleotide-dependent protein kinases. VI. Isolation and partial purification of a protein kinase activated by guanosine 3',5'-monophosphate. , 1970, The Journal of biological chemistry.

[131]  Thomas Kreis,et al.  Guidebook to cytoskeletal and motor proteins , 1999 .

[132]  Kenneth M. Yamada,et al.  Molecular interactions in cell adhesion complexes. , 1997, Current opinion in cell biology.

[133]  J. Bischoff.  Perspectives Series : Cell Adhesion in Vascular , 1997 .

[134]  A. Hassid,et al.  Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells. , 1996, Cardiovascular research.

[135]  K Konstantopoulos,et al.  Perspectives Series: Cell Adhesion in Vascular Biology Effects of Fluid Dynamic Forces on Vascular Cell Adhesion , 1996 .

[136]  T. Imaizumi,et al.  Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. , 1996, Hypertension.

[137]  S. Shattil,et al.  Chapter 13 Integrin Signaling and the Platelet Cytoskeleton , 1996 .

[138]  T. Lincoln,et al.  cGMP signaling through cAMP- and cGMP-dependent protein kinases. , 1995, Advances in pharmacology.

[139]  T. Lincoln,et al.  Cyclic guanosine monophosphate-dependent protein kinase is targeted to intermediate filaments and phosphorylates vimentin in A23187-stimulated human neutrophils. , 1995, Blood.

[140]  S H Snyder,et al.  Nitric oxide in the nervous system. , 1995, Annual review of pharmacology and toxicology.

[141]  F. Murad,et al.  Nitric oxide : biochemistry, molecular biology, and therapeutic implications , 1995 .

[142]  J. Corbin,et al.  Structure and function of cyclic nucleotide-dependent protein kinases. , 1994, Annual review of physiology.

[143]  U Walter,et al.  Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. , 1989, Reviews of physiology, biochemistry and pharmacology.

[144]  H. Cheng,et al.  Peptide inhibitors of cAMP-dependent protein kinase. , 1988, Methods in enzymology.

[145]  U. Walter.  Cyclic-GMP-regulated enzymes and their possible physiological functions. , 1984, Advances in cyclic nucleotide and protein phosphorylation research.

[146]  D. Hr.  Cyclic GMP-dependent protein kinase in intestinal brushborders. , 1981 .

[147]  Corbin Jd,et al.  Comparison of cAMP and cGMP-dependent protein kinases. , 1978 .